Uncommon
PrivateLast Round
Series A
Jun 9, 2023
Total Funding Raised
$33.77M
Company Overview
Uncommon is a biotechnology company that developed RNA-based technology for cultivated meat production before pivoting to focus on programmable RNA therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
RNA therapeuticsSymphoRNAdrug discoverynucleic acid deliverybiotech R&DRNA medicineAI-augmented drug designbiotech platformcultivated meatlab-grown meatfood techbiotech licensingRNA foundation modelsdrug development
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Uncommon Comparables
Compare Uncommon with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eleven Therapeutics | 58% | |
| CamGene Therapeutics | 58% | |
| SymphoRNA | 58% | |
Uncommon Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 9, 2023 | ||||
| Grant | Feb 1, 2021 | ||||
| Seed | Jan 1, 2020 | ||||
| Pre Seed | Nov 1, 2018 |
Uncommon Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| East Alpha | Series A |
| Lowercarbon Capital | Series A |
| Balderton Capital | Series A |
| Redalpine | Series A |
Uncommon Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Uncommon's valuation, stock price, and market status.
Firmographic Details
HeadquartersCambridge
Employee Range8
Year Founded2017
Last FundingJun 9, 2023
See something wrong or outdated?